FIGURE
Fig. S5
- ID
- ZDB-FIG-141231-4
- Publication
- Schulte et al., 2014 - Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. S5
In vivo complementation and overexpression using human mRNA of MAP2K5, another gene harboring RLS risk alleles identified by means of GWAS3; 4. Suppression of map2k5 results in a reduction of the size of the optic tectum in a similar manner to that seen upon in vivo complementation of MEIS1. Asterisks denote significance levels as determined by Student′s t-test (*** p-value < 0.0001). MO=morpholino, wt=wildtype |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
| Fish: | |
|---|---|
| Knockdown Reagent: | |
| Observed In: | |
| Stage: | Protruding-mouth |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Am. J. Hum. Genet.